TNIP1 is a corepressor of agonist-bound PPARs

• Published in: Archives of biochemistry and biophysics 2011-12, Vol.516 (1), p.58-66
• Main Authors: Flores, Anthony M., Gurevich, Igor, Zhang, Carmen, Ramirez, Vincent P., Devens, Taylor R., Aneskievich, Brian J.
• Format: Article
• Language: English
• Subjects: Animals; cDNA libraries; Cell Line; Cercopithecus aethiops; Co-Repressor Proteins - metabolism; Coactivator; complementary DNA; Corepressor; COS Cells; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Gene Expression; Gene Library; gene silencing; Humans; keratinocytes; Keratinocytes - metabolism; Nuclear receptors; Peroxisome Proliferator-Activated Receptors - genetics; Peroxisome Proliferator-Activated Receptors - metabolism; PPAR; Protein Binding; Protein Interaction Mapping; signal transduction; TNIP1; Transcription; transcription (genetics); transcription factor NF-kappa B; Transcriptional Activation
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1016/j.abb.2011.08.014

► We report TNIP1is a corepressor of agonist-bound PPARs. ► TNIP1 was previously known to associate with HIV proteins and repress NF-κB. ► TNIP1 binds PPARs in a manner typical of coactivators but represses their activity. ► TNIP1 has separable activation and repression domains. ► Corepressors such as TNIP1 may contribute to combinatorial transcription regulation. Nuclear receptor (NR) coregulators include coactivators, contributing to holoreceptor transcriptional activity, and corepressors, mediating NR target gene silencing in the absence of hormone. We identified an atypical NR coregulator, TNFα-induced protein 3-interacting protein 1 (TNIP1), from a peroxisome proliferator activated receptor (PPAR) α screen of a human keratinocyte cDNA library. TNIP1’s complex nomenclature parallels its additional function as an NF-κB inhibitor. Here we show TNIP1 is an atypical NR corepressor using two-hybrid systems, biochemical studies, and receptor activity assays. The requirements for TNIP1–PPAR interaction are characteristic for coactivators; however, TNIP1 partially decreases PPAR activity. TNIP1 has separable transcriptional activation and repression domains suggesting a modular nature to its overall effect. It may provide a means of lowering receptor activity in the presence of ligand without total loss of receptor function. TNIP1’s multiple roles and expression in several cell types suggest its regulatory effect depends on its expression level and the expression of other regulators in NR and/or NF-κB signaling pathways. As a NR coregulator, TNIP1 targeting agonist-bound PPAR and reducing transcriptional activity offers control of receptor signaling not available from typical corepressors and may contribute to combinatorial regulation of transcription.